CymitQuimica logo

CAS 2002-44-0: L-Prolil-L-leucilglicinamide

Descrizione:
L-Prolil-L-leucilglicinamide, con il numero CAS 2002-44-0, è un peptide sintetico che consiste in tre amminoacidi: prolina, leucina e glicina. Questo composto è caratterizzato dalla sua sequenza specifica, che influenza la sua attività biologica e le interazioni. Peptidi come L-Prolil-L-leucilglicinamide sono spesso studiati per i loro potenziali ruoli in vari processi fisiologici, inclusi i loro effetti sulla neurotrasmissione e sulla regolazione ormonale. La presenza di prolina nella sua struttura può contribuire a proprietà conformazionali uniche, influenzando potenzialmente la sua stabilità e solubilità. Inoltre, la natura idrofobica della leucina può influenzare le sue interazioni con membrane biologiche o proteine. L-Prolil-L-leucilglicinamide può anche mostrare affinità di legame specifiche per i recettori, rendendolo di interesse nella ricerca farmacologica. In generale, le caratteristiche di questo composto, inclusa la sua composizione di amminoacidi e sequenza, giocano un ruolo cruciale nel determinare la sua funzionalità e le potenziali applicazioni in biochimica e chimica medicinale.
Formula:C13H24N4O3
InChI:InChI=1S/C13H24N4O3/c1-8(2)6-10(12(19)16-7-11(14)18)17-13(20)9-4-3-5-15-9/h8-10,15H,3-7H2,1-2H3,(H2,14,18)(H,16,19)(H,17,20)/t9-,10-/m0/s1
InChI key:InChIKey=NOOJLZTTWSNHOX-UWVGGRQHSA-N
SMILES:[C@@H](NC(=O)[C@@H]1CCCN1)(C(NCC(N)=O)=O)CC(C)C
Sinonimi:
  • 2-Pyrrolidinecarboxamide, N-[1-[(carbamoylmethyl)carbamoyl]-3-methylbutyl]-
  • 26: PN: US6093797 PAGE: 15 claimed protein
  • 27: PN: US6093797 PAGE: 15 claimed protein
  • 2: PN: WO2009039992 PAGE: 107 claimed protein
  • 7-9-Oxytocin
  • <span class="text-smallcaps">L</smallcap>-Proline-<smallcap>L</span>-leucine-glycine-amide
  • <span class="text-smallcaps">L</smallcap>-Prolyl-<smallcap>L</span>-leucyl-glycine amide
  • <span class="text-smallcaps">L</smallcap>-Prolyl-<smallcap>L</span>-leucylglycinamide
  • <span class="text-smallcaps">L</smallcap>-Prolyl-<smallcap>L</span>-leucylglycylamide
  • Glycinamide, <span class="text-smallcaps">L</smallcap>-prolyl-<smallcap>L</span>-leucyl-
  • H-Pro-Leu-Gly-NH2
  • Vedi altri sinonimi
Ordinare per
5 prodotti.
  • Melanocyte-Stimulating Hormone-Release Inhibiting Factor
    Bachem
    + Info

    Melanocyte-Stimulating Hormone-Release Inhibiting Factor

    CAS:
    MIF-I, the C-terminal tripeptide of oxytocin, has been shown to be active in numerous behavioral tests and clinical situations.
    Formula:C13H24N4O3
    Purezza:> 99%
    Colore e forma:White
    Peso molecolare:284.36

    Ref: 01-4000343

    1g
    129,00€
    5g
    493,00€
  • (S)-N-((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide
    Fluorochem
    + Info

    (S)-N-((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide

    CAS:
    Purezza:95.0%
    Peso molecolare:284.3599853515625

    Ref: 10-F242063

    1g
    Prezzo su richiesta
    250mg
    Prezzo su richiesta
  • H-PRO-LEU-GLY-NH2
    Indagoo
    + Info

    H-PRO-LEU-GLY-NH2

    CAS:
    Formula:C13H24N4O3
    Colore e forma:Solid
    Peso molecolare:284.3547

    Ref: IN-DA00BCS5

    ne
    Prezzo su richiesta
  • MSH-Release Inhibiting Factor
    Biosynth
    + Info

    MSH-Release Inhibiting Factor

    CAS:
    MSH-Release Inhibiting Factor (MRIF) has been shown to be a potent inhibitor of the release of proinflammatory cytokines. It is derived from the acid methyl ester of mouse serum, and has been shown to inhibit the release of tumor necrosis factor-α (TNF-α) in animal studies. MRIF has also been shown to have anti-diabetic effects in mice. MRIF inhibits the production of inflammatory cytokines by blocking TNF-α at a molecular level. This protein binds to progesterone receptor and prevents it from interacting with its ligand, which is necessary for cancer cell growth. The expression system for this protein is E. coli, and it can be used as an immunosuppressant in animal studies. MRIF also blocks TNF-α activity by inhibiting transcriptional activation of NFκB and AP-1, which are proteins that regulate gene expression.
    Formula:C13H24N4O3H2O
    Purezza:Min. 95%
    Peso molecolare:293.36 g/mol

    Ref: 3D-PMI-4024

    25mg
    165,00€
    100mg
    169,00€
  • Melanocyte-Stimulating Hormone-Release Inhibiting Factor
    Biosynth
    + Info

    Melanocyte-Stimulating Hormone-Release Inhibiting Factor

    CAS:
    Melanocyte-Stimulating Hormone-Release Inhibiting Factor (MSH-RF) is a synthetic peptide that inhibits the release of melanin from melanocytes. MSH-RF has been shown to be a useful treatment for melatonin deficiency, which may be related to immune system disorders such as infectious diseases and autoimmune diseases. It has also been shown to have significant interactions with other hormones such as dopamine, affecting locomotor activity and the ph optimum, among other biological properties. The structure of MSH-RF has been determined using X-ray crystallography on an amide bond. This peptide hormone is found in human serum and is involved in regulating camp levels.
    Formula:C13H24N4O3
    Purezza:Min. 95%
    Peso molecolare:284.35 g/mol

    Ref: 3D-FM109235

    1g
    393,00€
    2g
    749,00€
    5g
    1.096,00€
    500mg
    314,00€